Palliative care services for advanced non-malignant lung diseases in Taiwan
Ting-Tat Chan(Chia-Yi Christian Hospital), C R Chen(Chia-Yi Christian Hospital), J D Wang(National Cheng Kung University), Jeng‐Yuan Hsu(Taichung Veterans General Hospital), M.S. Lin(Chia-Yi Christian Hospital), Chong‐Jen Yu(National Taiwan University Hospital), Martyn R Partridge(Imperial College London), Yuan‐Horng Yan(Kuang Tien General Hospital)
Cited by 0
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|The Lancet Oncology|2015|980
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
|Journal of Allergy and Clinical Immunology|2010|746
A new perspective on concepts of asthma severity and control
|European Respiratory Journal|2008|475